This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Aleafia Health Ausschüttungen und Rückkäufe

Zukünftiges Wachstum Kriterienprüfungen 0/6

Aleafia Health hat in der Vergangenheit keine Dividende gezahlt.

Wichtige Informationen

n/a

Dividendenausschüttung

-69.7%

Rückkaufsrendite

Gesamte Aktionärsrendite	-69.7%
Zukünftige Dividendenrendite	n/a
Wachstum der Dividende	n/a
Nächster Dividendenzahlungstermin	n/a
Ex-Dividendendatum	n/a
Dividende pro Aktie	n/a
Ausschüttungsquote	n/a

Jüngste Updates zu Dividenden und Rückkäufen

Keine Aktualisierungen

Recent updates

Fewer Investors Than Expected Jumping On Aleafia Health Inc. (TSE:AH)

Apr 19

Why Aleafia Health Inc. (TSE:AH) Could Be Worth Watching

Jan 04

CA$0.29: That's What Analysts Think Aleafia Health Inc. (TSE:AH) Is Worth After Its Latest Results

Feb 17

Analysts Are Betting On Aleafia Health Inc. (TSE:AH) With A Big Upgrade This Week

Feb 16

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Dividende je Aktie von AH in der Vergangenheit stabil war.

Wachsende Dividende: Unzureichende Daten, um festzustellen, ob die Dividendenzahlungen von AH gestiegen sind.

Dividendenrendite im Vergleich zum Markt

Aleafia Health Dividendenrendite im Vergleich zum Markt

Wie sieht die Dividendenrendite von AH im Vergleich zum Markt aus?
Segment	Dividendenrendite
Unternehmen (AH)	n/a
Untere 25 % des Marktes (CA)	1.8%
Markt Top 25 % (CA)	6.2%
Branchendurchschnitt (Pharmaceuticals)	2.4%
Analystenprognose (AH) (bis zu 3 Jahre)	n/a

Bemerkenswerte Dividende: Es ist nicht möglich, die Dividendenrendite von AH im Vergleich zu den unteren 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Hohe Dividende: Es ist nicht möglich, die Dividendenrendite von AH im Vergleich zu den besten 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: Unzureichende Daten zur Berechnung der Ausschüttungsquote von AH, um festzustellen, ob die Dividendenzahlungen durch die Gewinne gedeckt sind.

Barausschüttung an die Aktionäre

Cashflow-Deckung: Es ist nicht möglich, die Nachhaltigkeit der Dividende zu berechnen, da AH keine Ausschüttungen gemeldet hat.

This company listing is no longer active

Aleafia Health Ausschüttungen und Rückkäufe

Zukünftiges Wachstum Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Updates zu Dividenden und Rückkäufen

Recent updates

Aleafia Health Obtains Creditor Protection to Pursue Restructuring and Sale Process

New major risk - Financial position

Full year 2023 earnings released: CA$0.09 loss per share (vs CA$0.42 loss in FY 2022)

Red White & Bloom Brands Inc. (CNSX:RWB) entered into a binding letter agreement to acquire Aleafia Health Inc. (TSX:AH) from shareholders for CAD 74.98 million.

Fewer Investors Than Expected Jumping On Aleafia Health Inc. (TSE:AH)

Third quarter 2023 earnings released: CA$0.062 loss per share (vs CA$0.22 loss in 3Q 2022)

Price target increased by 47% to CA$0.25

Aleafia Health Inc. to Report Q3, 2023 Results on Feb 08, 2023

Aleafia Health Inc. Announces Board Changes

Now 24% undervalued

Why Aleafia Health Inc. (TSE:AH) Could Be Worth Watching

High number of new and inexperienced directors

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Aleafia Health Inc. to Report Q2, 2023 Results on Nov 09, 2022

Aleafia Health Expands Sunday Market House of Brands with Coveted Lineup of Winter Product Launches

Aleafia Health Announces TSX Decision to Extend Delisting Review Period to November 29, 2022

Aleafia Health Inc. to Report Q2, 2022 Results on Aug 11, 2022

Consensus forecasts updated

Aleafia Health Inc., Annual General Meeting, Sep 27, 2022

Consensus EPS estimates fall by 586%

Full year 2022 earnings released: CA$0.42 loss per share (vs CA$0.84 loss in FY 2021)

Aleafia Health Inc. Reaffirms Revenue Guidance for the Fiscal Year 2023

Aleafia Health Inc. announced that it has received CAD 5.6225 million in funding

Aleafia Health Inc. announced that it expects to receive CAD 5.6225 million in funding

High number of new and inexperienced directors

Aleafia Health Inc. Reaffirms Earnings Guidance for the Fiscal Year 2022

Consensus forecasts updated

Aleafia Health Inc. Announces Impairment of Property, Plant & Equipment for the Fourth Quarter Ended December 31, 2021

CA$0.29: That's What Analysts Think Aleafia Health Inc. (TSE:AH) Is Worth After Its Latest Results

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Analysts Are Betting On Aleafia Health Inc. (TSE:AH) With A Big Upgrade This Week

Aleafia Health Inc. to Report Q4, 2021 Results on Feb 14, 2022

Aleafia Health Inc. Announces Executive Changes

Third quarter 2021 earnings released: CA$0.25 loss per share (vs CA$0.066 loss in 3Q 2020)

Here's Why Aleafia Health (TSE:AH) Can Afford Some Debt

Consensus forecasts updated

Price target decreased to CA$0.70

Aleafia Health Launches Premium Cannabis Brand Nith & Grand

Aleafia Health Expands Bogart’s Kitchen Edibles Portfolio with Launch of Salted Caramel Pretzel Bites

Aleafia Health Inc. Announces It Has Largely Completed Planting Across 86 Acres At Its Outdoor Cultivation Facility in Port Perry, Ont

Aleafia Health Inc. Expands Trailblazing Wellness Brand Noon & Night with Launch of Freshly Minted Roll-On

Chief Executive Officer recently bought CA$50k worth of stock

CFO & Corporate Secretary Benjamin Ferdinand has left the company

Consensus forecasts updated

Chief Executive Officer recently bought CA$50k worth of stock

Aleafia Health Inc.'s Everyday Cannabis Brand Divvy Launches Large Format Dried Flower Portfolio

Price target decreased to CA$1.06

First quarter 2021 earnings released: CA$0.036 loss per share (vs CA$0.022 loss in 1Q 2020)

Aleafia Health Inc. Secures Health Canada Research Licence

Full year 2020 earnings released: CA$0.85 loss per share (vs CA$0.18 loss in FY 2019)

Aleafia Health Expands Adult-Use Presence with Entrance in Saskatchewan, New Provincial Market

Aleafia Health Inc. has completed a Composite Units Offering in the amount of CAD 19.92 million.

Aleafia Health Inc. Launches THC Soft Chews Under its Edibles Brand Bogart’s Kitchen

Aleafia Health Inc. to Report Q4, 2020 Results on Mar 25, 2021

Analysts Expect Aleafia Health Inc. (TSE:AH) To Breakeven Soon

Aleafia Health Secures Licence for Toronto Distribution Centre, Expanding Supply Chain and Ecommerce Opportunity

Aleafia Health Inc. Launches Sunday Market House of Brands

New 90-day high: CA$1.09

Aleafia Health Inc. Announces Directorship Appointments

Aleafia Health Announces Resignation Rhonda Lawson as Director

Unifor and Aleafia Health Enter Exclusive Agreement to Support Medical Cannabis Coverage for Members

Introducing Aleafia Health (TSE:AH), A Stock That Climbed 29% In The Last Year

Aleafia Health Inc. Enters Definitive Supply Agreement with Apipharm

New 90-day high: CA$0.60

Unifor and Aleafia Health Inc. Partner on Groundbreaking Medical Cannabis Coverage

Would Aleafia Health (TSE:AH) Be Better Off With Less Debt?

Aleafia Health Enters into Supply Agreement with Robes Cannabis Inc

Aleafia Health Launches High Potency CBD 50 Cannabis Oil

Aleafia Health Inc. Launches Kin Slips® Rapid Onset Cannabis-Infused Sublingual Strips

Third quarter 2020 earnings released: CA$0.066 loss per share

Aleafia Health Inc. Announces Successful Outdoor Harvest Accelerates Product Portfolio Expansion

Aleafia Health Inc. to Report Q3, 2020 Results on Nov 11, 2020

Aleafia Health Inc. Launches Cannabis 2.0 Portfolio with 510 Vape Cartridges Featuring Unique Formulations

New 90-day low: CA$0.46